SMTL ID : 8yxa.2 (1 other biounit)

Crystal structure of the HSA complex with cefazolin and myristate

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x X56: (6~{R},7~{R})-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxidanylidene-7-[2-(1,2,3,4-tetrazol-1-yl)ethanoylamino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid(Non-covalent)

X56.1: 13 residues within 4Å: Chain A: V.116, R.117, P.118, M.123, F.134, Y.138, I.142, H.146, Y.161, L.182, R.186, G.189, K.190 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:I.142 Salt bridges: A:R.117

2 x MYR: MYRISTIC ACID(Non-covalent)

MYR.2: 12 residues within 4Å: Chain A: L.14, L.22, Y.150, P.152, L.250, L.251, A.254, R.257, A.258, L.283, L.284, S.287 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.14, A:L.22, A:P.152, A:L.250, A:L.251, A:A.254, A:L.284 Hydrogen bonds: A:Y.150, A:Y.150, A:S.287, A:S.287 MYR.3: 13 residues within 4Å: Chain A: W.214, R.218, L.219, R.222, L.238, V.241, H.242, R.257, L.260, I.264, S.287, I.290, A.291 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.214, A:L.219, A:L.238, A:L.260, A:I.264, A:I.290, A:A.291 Salt bridges: A:H.242, A:R.257

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kawai, A. et al., Interaction of Cephalosporins with Human Serum Albumin: A Structural Study. J.Med.Chem. (2024)

Release Date

2024-08-07

Peptides

Serum albumin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serum albumin

Related Entries With Identical Sequence